CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
Permethrin-treated lesu +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05391230
NCT05391230N/ACompleted
CompareCT.gov

IGHID 12128 - Getting Malaria "Off the Backs" of Women and Children in Western Uganda

University of North Carolina, Chapel Hill·interventional·Posted May 25, 2022·Updated Jul 14, 2025

In Brief

A clinical study evaluating Permethrin-treated lesu and Untreated lesu for Malaria and P. Falciparum. Completed, enrolled 400 participants across 1 site.

Detailed Summary

The scientific objective of this study is to test the protective effect of permethrin-treated lesus against P. falciparum malaria in infants and young children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria, P. Falciparum
CountriesUganda
CollaboratorsDoris Duke Charitable Foundation

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 25, 2022
Enrollment StartJun 3, 2022
Primary CompletionOct 19, 2024
Study CompletionNov 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.1 years ago

Interventions

Permethrin-treated lesuother

0.5% permethrin soaked baby wraps (lesus)

Untreated lesuother

Water soaked baby wraps (lesus)